507 results on '"Toss, Michael S"'
Search Results
2. L1-regularized neural ranking for risk stratification and its application to prediction of time to distant metastasis in luminal node negative chemotherapy na\'ive breast cancer patients
3. Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application
4. Novel 2 Gene Signatures Associated With Breast Cancer Proliferation: Insights From Predictive Differential Gene Expression Analysis
5. Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers
6. Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression
7. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development
8. Deciphering the Morphology of Tumor-Stromal Features in Invasive Breast Cancer Using Artificial Intelligence
9. The characteristics and clinical significance of atypical mitosis in breast cancer
10. Potential quality pitfalls of digitalized whole slide image of breast pathology in routine practice
11. Defining the area of mitoses counting in invasive breast cancer using whole slide image
12. Deciphering the Role of ASPM in Breast Cancer: A Comprehensive Multicohort Study.
13. The combination phenotype of B-cell specific Moloney murine leukaemia virus integration site 1 (BMI1) and CD44+/CD24−/low associates with poor clinicopathological features in African patients with breast cancer
14. Atypia in breast pathology: what pathologists need to know
15. Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
16. Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers
17. The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS)
18. Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
19. Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
20. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population
21. The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ
22. Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases
23. A novel prognostic two-gene signature for triple negative breast cancer
24. Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
25. Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies
26. Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer
27. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer
28. The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ
29. The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
30. The prognostic significance of immune microenvironment in breast ductal carcinoma in situ
31. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer
32. Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers
33. Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ
34. Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study
35. The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts
36. Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ
37. ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers
38. L1-Regularized Neural Ranking for Risk Stratification and Its Application to Prediction of Time to Distant Metastasis in Luminal Node Negative Chemotherapy Naïve Breast Cancer Patients
39. Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application
40. Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ
41. Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast
42. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer
43. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
44. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy
45. Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
46. The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
47. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
48. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion
49. RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers
50. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.